Q2 2020

Filed Aug 5, 2021 · 10-Q · 401 days after period end · 0001493152-21-018715

Q2 2020 · 10-Q

Revenue

$6.24K

−38.9% vs Q2 2019

Net Income

-$1.51M

N/M vs Q2 2019

EPS Diluted

$0.00

— vs Q2 2019

Gross Profit$2,555−60.3%

Operating Income

Same quarter

Metric	Q2 2020	Q2 2019	Q2 2018	Q2 2017
Revenue	$6.24K	$10.22K	$29.38K	$33.18K
Net Income	-$1.51M	-$1.67M	-$1.35M	-$1.12M
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR